KOD shares climbed roughly +155.8% over 30 days, from about $37.06 on September 1, 2026 to $94.80 on September 30, 2026. The surge followed positive Phase 3 DAYBREAK trial results announced September 28, 2026, showing Zenkuda and tabirafusp-ted met their primary endpoints in wet age-related macular degeneration (wet AMD).

Vicor Corporation (VICR) shares climbed about 53.95% over the last 30 days, rising from a closing price of $187.68 on August 31, 2026 to $288.94 on September 30, 2026. The rally was driven primarily by non-exclusive licensing of its Vertical Power Delivery (VPD) technology and two consecutive upward revisions to third-quarter revenue guidance.

Charter Communications (CHTR) fell roughly 27% over the last 30 days, with the latest closing price near $110.90 versus $152.44 a month earlier. The decline reflects mounting concerns about broadband subscriber losses, with analysts flagging steeper third-quarter customer declines.

Paychex (PAYX) shares fell roughly 22.6% over the trailing 30 days, from a close of $127.34 on August 31 to $98.50 by September 30. The decline accelerated after fiscal Q1 2027 results on September 23, when the stock dropped nearly 9% in a single session despite beating earnings estimates.

Axon Enterprise shares fell roughly 25% over the past 30 days, sliding from about $567 to near $423 on a closing basis. A $1 billion convertible note offering announced in mid-September sparked concerns over dilution and pressured the stock sharply.

Micron reported record fiscal Q4 2026 revenue of $54.2 billion, up 379% year over year, beating the roughly $51.1 billion consensus estimate. Non-GAAP diluted earnings per share (EPS) reached $33.42, above analyst expectations of about $31.61.

INTW is a leveraged single-stock exchange-traded fund (ETF) seeking 200% of Intel (INTC) 's daily return, and it has surged roughly 80% over the last 30 days. The move mirrors a sharp rally in Intel shares as demand for server central processing units (CPUs) tied to agentic artificial intelligence (AI) accelerated.

METU gained roughly 68% over the trailing 30 days, climbing from about $18.92 to $31.84 as 2x daily leverage amplified a sharp rally in its underlying single stock. Over the trailing quarter the fund is up roughly 57% , after a volatile path that included a mid-summer drawdown followed by a powerful recovery.

MVLL seeks to deliver two times (2x) the daily return of Marvell Technology (MRVL) stock, making it a high-beta, single-issuer leveraged vehicle rather than a diversified fund. The ETF advanced roughly 52% over the last 30 days, recovering sharply from a steep mid-summer drawdown.

TSMX gained roughly 19% over the last 30 days, amplifying a roughly 10% advance in underlying Taiwan Semiconductor Manufacturing stock through 2X daily leverage. Over the last quarter, the fund was still down about 14%, reflecting a sharp July drawdown and the path-dependent nature of daily-rebalanced leverage.

IRE, a leveraged single-stock ETF seeking 200% of the daily return of IREN Limited, advanced roughly 16% over the trailing 30 days. The rally reflected a rebound in IREN shares after a post-earnings selloff, a Wall Street double upgrade, and progress in the company's AI cloud buildout.

GEN is a consumer cybersecurity and digital-trust leader, while PAYC is a cloud-based human capital management (HCM) and payroll software provider. GEN recently pulled back roughly 30% from its 52-week high, though management raised fiscal 2027 revenue and earnings guidance amid double-digit bookings growth.

Micron posted record fiscal fourth-quarter revenue of $54.23 billion , up 379% year over year. Non-GAAP (non-Generally Accepted Accounting Principles) diluted earnings per share (EPS) reached $33.42 , above analyst consensus.

Micron Technology reports fiscal fourth-quarter 2026 results on September 30, 2026, after the market close. Management has guided to revenue of $50.0 billion (±$1.0 billion) and non-GAAP earnings per share (EPS) of $31.00 (±$1.00).

GOOGL gained +3.00% to roughly $351.14 during regular trading hours, up from Tuesday's close of $340.92. Primary catalyst: softer-than-expected August core PCE inflation (+0.2% m/m vs. +0.3% expected) eased near-term Fed rate-hike fears, lifting risk assets and megacap tech.

Cadence Design Systems ( CDNS ) delivered a beat-and-raise quarter with a record $8 billion backlog, but lowered its full-year earnings outlook as it integrates the Hexagon acquisition. Synopsys ( SNPS ) posted strong results and raised guidance, with its Ansys acquisition contributing roughly $2.98 billion in expected fiscal 2026 revenue.

The $1.00 figure is a single published research target from First Berlin Equity Research, not a multi-analyst consensus; NWBO has essentially one active coverage note. With the stock near $0.17, reaching $1.00 would require a gain of roughly 490%, a very large move by any standard.

NIVF is up about +127% in regular trading, rebounding to ~$0.16 from a prior-session close of $0.07. The jump follows Tuesday's -79% plunge after the company priced a $1.25 million public offering at a steeply discounted $0.07 per share.

SHFS is quoted up roughly +1050% to about $1.38 from a $0.12 prior close, but the jump is mechanical rather than driven by genuine buying. The surge reflects a 1-for-12 reverse stock split that took effect September 30, 2026, consolidating every 12 shares into one and multiplying the quoted price about 12x.

Pacific Biosciences (PACB) shares climbed roughly 73% over the last 30 days, rising from a closing price of $1.355 on August 31, 2026 to approximately $2.345 in late September. The rally was driven by a series of partnership and contract announcements tied to PacBio's HiFi long-read sequencing technology, including the Sampled–U.S. Department of Veterans Affairs agreement.